Angelica Brandelius

Melatonin is the active ingredient in medicines such as Circadin and Melatonin Neurim. These medicines are used for short-term treatment of primary insomnia, where sleep quality is poor. But how could this affect your weight?

‍

There are many myths and prejudices surrounding overweight and obesity. They are deeply rooted in society and can create guilt, shame and misunderstanding, despite obesity being a complex medical condition influenced by biology, environment and living conditions. When myths dominate the conversation, they obscure what actually helps. In this article, we address common misconceptions and highlight knowledge that truly makes a difference.

‍

‍

Body mass index (BMI) is a commonly used measure of the relationship between weight and height in weight loss and obesity treatment, but it does not provide the full picture of your health. At Yazen, we therefore complement BMI with body measurements and body composition to gain a better understanding of your body and develop more individualised strategies for sustainable weight loss.

‍

In this article, various aspects of treating overweight and obesity with the medication Mysimba are discussed, and information is provided on how the risk of disease can be reduced through conscious choices regarding diet, physical activity, and medical treatment.

‍

According to the WHO, overweight and obesity affect nearly 60 per cent of the adult population in Europe, highlighting the need for integrated treatment strategies that combine medical therapy with lifestyle changes (1).

We are in a new era of obesity treatment. GLP-1-based medicines have transformed the landscape – but real success is achieved when medication becomes part of a comprehensive approach that supports the whole person.

Long-term health and weight loss require more than medicine alone. It is when medical treatment is combined with lifestyle change and continuous guidance that meaningful, lasting progress becomes possible (1–2).

Trulicity is a medicine that contains the active substance dulaglutide. It is approved for the treatment of adults with type 2 diabetes to improve glycaemic control as a complement to a healthy diet and physical activity (1). The treatment may also contribute to weight loss (2–4).

Saxenda is a medicine used as support in the treatment of overweight and obesity. It contains the active substance liraglutide, which influences appetite regulation and helps reduce energy intake. When combined with lifestyle changes such as a healthy diet and regular physical activity, the treatment can support clinically significant weight loss (1).

‍

Rybelsus is a medicine containing the active substance semaglutide. It is approved for the treatment of adults with type 2 diabetes to improve glycaemic control as a complement to a healthy diet and physical activity.

The treatment may also contribute to weight loss (1,2).

‍